联系客服

600535 沪市 天士力


首页 公告 600535:天士力关于公司2021年度主要经营数据的公告

600535:天士力关于公司2021年度主要经营数据的公告

公告日期:2022-03-31

600535:天士力关于公司2021年度主要经营数据的公告 PDF查看PDF原文

      证券代码:600535        证券简称:天士力        编号:临 2022-027 号

                      天士力医药集团股份有限公司

                  关于公司 2021 年度主要经营数据的公告

          本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述

      或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。

          根据上海证券交易所发布的上市公司分行业信息披露指引《上市公司行业信

      息披露指引第七号——医药制造》及《关于做好上市公司 2021 年度报告披露工作

      的通知》相关要求,现将公司 2021 年度主要经营数据披露如下:

          一、报告期内分行业经营数据

                                                                                单位:元  币种:人民币

                    主营业务收入                              主营业务成本                    毛利率(%)

行业                                      增长率                                    增长率  本期  上年同  增长
          本期累计      上年同期累计    (%)    本期累计      上年同期累计  (%)  累计  期累计    率

医药

工业  6,654,091,503.55  6,382,917,987.78    4.25  1,763,147,188.18  1,693,105,163.80    4.14  73.50    73.47  0.03

医药

商业  1,244,008,754.64  7,122,379,412.36    -82.53  885,050,183.19  6,372,977,722.52  -86.11  28.85    10.52  18.33

合计  7,898,100,258.19  13,505,297,400.14    -41.52  2,648,197,371.37  8,066,082,886.32  -67.17  66.47    40.27  26.20

                                                                                单位:元  币种:人民币

 分治疗领域        营业收入            营业成本        毛利率    营业收入比上  营业成本比上  毛利率比上年增
                                                        (%)    年增减(%)    年增减(%)      减(%)

 心脑血管        4,786,835,617.25    1,180,608,762.57      75.34          14.91            6.71              1.90

  抗肿瘤          392,423,197.61      120,801,414.36      69.22          -52.33            0.58            -16.19

 感冒发烧          287,200,978.95      144,246,553.00      49.78          -15.25          -18.76              2.17

 肝病治疗          548,842,151.32      96,031,525.89      82.50          20.55          14.92              0.86


 分治疗领域        营业收入            营业成本        毛利率    营业收入比上  营业成本比上  毛利率比上年增
                                                        (%)    年增减(%)    年增减(%)      减(%)

  其他            638,789,558.42      221,458,932.36      65.33            6.47            7.77            -0.42

医药工业小计      6,654,091,503.55    1,763,147,188.18      73.50            4.25            4.14              0.03

医药商业小计      1,244,008,754.64      885,050,183.19      28.85          -82.53          -86.11            18.33

  合计          7,898,100,258.19    2,648,197,371.37      66.47          -41.52          -67.17            26.20

                                                                              单位:元  币种:人民币

    分产品          营业收入          营业成本      毛利率  营业收入比上  营业成本比上年  毛利率比上年增减
                                                          (%)    年增减(%)    增减(%)          (%)

      中药          5,080,023,258.77    1,374,713,564.87    72.94          13.74            5.00              2.25

  化学制剂药      1,255,391,096.53      273,895,887.89    78.18        -23.78            0.60              -5.29

  化学原料药          67,295,638.59      27,428,647.55    59.24          25.55            3.52              8.68

    生物药          251,381,509.66      87,109,087.87    65.35          16.52            2.30              4.81

  医药工业小计      6,654,091,503.55    1,763,147,188.18    73.50          4.25            4.14              0.03

  医药商业小计      1,244,008,754.64      885,050,183.19    28.85        -82.53          -86.11              18.33

      合计          7,898,100,258.19    2,648,197,371.37    66.47        -41.52          -67.17              26.20

          报告期内,公司医药商业收入较去年同期下降 82.53%,主要系公司 2020 年

      8 月处置天士营销所致;公司抗肿瘤产品收入较去年同期下降 52.33%,主要系蒂

      清产品执行中标集中采购新价格销售收入下降所致。

          二、报告期内分地区经营数据

                                                                                单位:元  币种:人民币

              地区          本期累计主营业务收入    上年同期累计主营业务收入        增长比例(%)

              天津市                12,285,594,167.40            10,852,200,833.33                      13.21

              北京市                                -              298,738,575.19                    -100.00

              广东省                    20,730,744.23              578,224,025.37                      -96.41

              山东省                    248,753,294.11              348,004,894.72                      -28.52

              陕西省                    78,302,631.02            2,671,154,763.77                      -97.07

              湖南省                                -              569,541,238.40                    -100.00


    地区          本期累计主营业务收入    上年同期累计主营业务收入        增长比例(%)

  辽宁省                    862,456,838.56            1,821,115,370.37                      -52.64

  江苏省                    891,556,568.43            1,329,182,895.86                      -32.92

  上海市                    251,370,868.88              215,964,075.68                      16.39

  山西省                                -            1,076,047,684.46                    -100.00

    其他                    181,942,288.
[点击查看PDF原文]